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n	 INTRODUCTION
IgG4-related disease (IgG4-RD) is a newly recognized fibroinflammatory 
pathological entity encompassing several 
conditions previously regarded as separate 
diseases, such as chronic sclerosing sialad-
enitis (Küttner’s) tumor, Riedel thyroiditis, 
Mikulicz’s disease, type 1 autoimmune 
pancreatitis (AIP), potentially involving 
any organ (1). 
IgG4-RD shows characteristic histopatho-
logic features with lymphoplasmacytic 
infiltrate, an increased number of IgG4+ 
cells, storiform fibrosis, obliterative phle-
bitis and, frequently, mild tissue eosino-
philia (2). 
Serum IgG4 may be elevated, yet this is 
not essential for the diagnosis, since a sig-
nificant proportion of patients with a con-
firmed histological diagnosis have normal 
serum levels (3). 
Patients with IgG4-RD usually show a 
prompt response to glucocorticoids, while 
new evidence for the role of immunosup-
pressant therapies is emerging. 
n	 CASE REPORT
S.M., a 54-year-old woman, was admitted 
to our department with diffuse arthromy-
algia, xerostomia, xerophtalmia, asthenia 
and mild dyspnea. She had been recently 
diagnosed with an undifferentiated connec-
tive tissue disease (UCTD) on the basis of 
her clinical picture and autoantibodies find-
ings characterized by the positivity of anti-
nuclear antibodies 1:320 with a nucleolar 
pattern, anti-Ro and anti-Scl70 positivity. 
Relevant medical history included favism 
without recent episodes of hemolytic crisis, 
pituitary adenoma and chronic lymphocyt-
ic thyroiditis. 
One year prior to presentation, the patient 
had undergone cardiac surgery with pros-
thetic replacement of the aortic arch due 
to the incidental finding, during a routine 
echocardiography, of a periaortic mass, 
confirmed by thoracic computed tomog-
raphy (CT) (Fig. 1A). Histology revealed 
perivascular fibrous connective tissue cuff-
ing with lymphoplasmacytic infiltrate. 
Amyloid deposits were excluded. The 
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etiology of the perivascular mass had not 
been further investigated and the patient 
had no signs of recurrence at the time of 
admission to our unit. The diagnosis of 
UCTD was confirmed, with a stable clini-
cal course. Nailfold capillaroscopy did not 
reveal any alteration. Schirmer’s test and 
sialometry were within normal ranges. 
Pulmonary function tests showed a mild, 
isolated, reduction of the carbon monox-
ide transfer factor. Echocardiography was 
stable, with preserved ejection fraction, no 
valvular defects and normal estimated sys-
tolic pulmonary artery pressure. 
High resolution CT excluded an intersti-
tial lung disease. Inflammatory markers 
were not raised and only a mild leukope-
nia (white blood cells count 3x103/μL, 
with normal differential) was detected with 
blood tests. The clinical examination re-
vealed a palpable, enlarged spleen with in-
constant, dull pain in the upper left abdom-
inal quadrant. An ultrasound examination 
showed the presence of a perivascular mass 
surrounding the splenic hilum. An abdomi-
nal contrast enhanced-CT disclosed a solid 
lesion with calcifications of 71x81 mm, ex-
tending to the pancreatic tail and lacking a 
clear cleavage with the organ parenchyma 
and no significant contrast enhancement. 
The splenic artery was completely sur-
rounded by the mass, with thrombosis of 
the splenic vein and a moderately enlarged 
spleen (Fig. 1B). Given the striking simi-
larities with the periaortic mass that had 
been previously removed, a diagnosis of 
IgG4-RD was hypothesized. The history 
of pituitary adenoma and chronic lympho-
cytic thyroiditis could also be part of the 
spectrum. Serum IgG4, even if not essen-
tial for the diagnosis, were evaluated and 
resulted within normal ranges (599 mg/L; 
normal values 80-1400 mg/L). A course of 
steroids 0.5 mg/kg was started, but it did 
not result in a significant reduction of the 
perisplenic mass. A surgical procedure of 
distal splenopancreasectomy was agreed 
with the patient for a better diagnostic defi-
nition. The histological analysis revealed 
perivascular fibrous connective tissue with 
calcifications and diffuse IgG4+ lympho-
plasmacitic inflammatory infiltrate, with 
IgG4+ >20/high power field (HPF) and a 
clearly increased IgG4+/IgG ratio, consis-
tent with retroperitoneal fibrosis. A new 
examination of the aortic histological spec-
imen confirmed the similarities between 
the two perivascular lesions, corroborating 
the diagnosis of IgG4-RD. The patient is 
undergoing a low-dose corticosteroid ther-
apy without evidence of new localization 
of the disease.
Figure 1 - Thoracic and abdominal contrast enhanced-computed tomography. A) Perivascular 
ulcerative mass involving the aortic arch (arrow). B) Solid lesion with calcifications completely 
surrounding the splenic artery, with thrombosis of the splenic vein and a moderately enlarged 
spleen, extending to the pancreatic tail (arrow). 
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n	 DISCUSSION
IgG4-RD is a newly recognized systemic 
disorder affecting a wide range of organ 
systems and unifying several conditions 
previously regarded as separate pathologi-
cal entities. Since the first reports of extra-
pancreatic involvement and elevated IgG4 
concentrations in AIP (4, 5), IgG4-RD has 
been found to potentially affect every organ, 
including the retroperitoneum, kidneys, 
gastrointestinal tract, bile ducts, liver, thy-
roid, salivary glands, arteries, lymphnodes, 
skin, central nervous system, lungs, pros-
tate and breast (1, 2). Clinically the disease 
manifests itself sub-acutely, with tumorous 
swelling and different grades of fibrosis 
of the affected sites. Multi-organ mani-
festations can be synchronous or follow a 
metachronous course (1). Highly specific 
histopathological features are the mainstay 
for diagnosis, characterized by lympho-
plasmacytic infiltrate, an increased number 
of IgG4+ cells >10/HPF and with a IgG+/
IgG4+ ratio >40%, storiform fibrosis, ob-
literative phlebitis and, frequently, mild 
tissue eosinophilia (2). Comprehensive 
diagnostic criteria for IgG4-RD proposed 
a serum IgG4 cutoff of 135 mg/dL (2) to 
be significant. Our patient did not present 
with an elevation of IgG4 serum levels. 
However, the diagnostic utility of serum 
IgG4 concentrations has been recently dis-
cussed. It is well-established that a relevant 
proportion of patients (up to 40%) with bi-
opsy-proven IgG4-RD have normal serum 
IgG4 concentrations (3). Elevated serum 
IgG4 have also been described in a number 
of different conditions, lacking diagnostic 
histopathological features of IgG4-RD, 
such as pancreatic cancer, cholangiocarci-
noma, primary sclerosing cholangitis, Cas-
tleman’s disease, systemic vasculitides (6, 
7). Serum IgG4 concentrations should be 
regarded as a useful test for the diagnosis, 
but have a poor specificity and a low posi-
tive predictive value in identifying patients 
with IgG4-RD (6). Another explanation for 
underestimated, false negative serum IgG4 
concentrations has been recently identified 
in the so-called prozone effect leading to 
unreliable measurements of IgG4 by neph-
elometry assay that occurs when samples 
are not adequately diluted, in the setting 
of extremely high IgG4 serum concentra-
tions (7). A consistent proportion of aortitis 
cases have been regarded as IgG4-related. 
Several authors reported that IgG4-RD ac-
counts for up to 7-9% of all cases of non-in-
fectious thoracic aortitis (8, 9). Increasing 
evidence of a strict relationship between 
retroperitoneal fibrosis (RPF), inflamma-
tory abdominal aortic aneurysm and IgG4-
RD is emerging (10). The wide spectrum 
of IgG4-RD actually includes a substantial 
proportion of patients with idiopathic RPF 
(11); distinctive characteristics are typical 
histopathological features of IgG4-RD, 
middle-aged and male predominance, a 
history of atopy, more frequent systemic 
symptoms and involvement of other or-
gans (10, 11). IgG4-RD usually shows a 
prompt response to glucocorticoids. In our 
case a dramatic response to steroids was 
not achieved; refractory cases of IgG4-RD 
have been reported and can be influenced 
by the degree of fibrosis within the affected 
tissue at the time of diagnosis (1, 12). Effi-
cacy of immunosuppressants (azathioprine, 
mycophenolate mofetil, and methotrexate) 
as steroid-sparing agents and as remission 
maintenance therapy has been reported in 
small case series (12, 13). Promising and 
swift clinical responses have been achieved 
with B-cell depletion too (1, 12, 14, 15). 
Rituximab has been proved particularly 
effective in targeting the short-lived cells 
responsible for the specific production of 
IgG4 subclasses of immunoglobulins (14, 
15). For selected cases, such as unstable 
aneurysmal aortic or large vessels lesions, 
surgery may still be necessary (13).
Our case emphasizes the importance of in-
creasing the awareness and recognition of 
an emerging clinical condition that can po-
tentially involve every medical field.
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